New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:03 EDTVEEVVeeva, Symphony Health Solutions announce partnership
Veeva Systems and Symphony Health Solutions announced their intent to partner to make it fast and easy for life sciences companies to use the combination of Veeva’s healthcare professional and healthcare organization data with Symphony Health Solutions’ performance data and analytical insights.
News For VEEV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
05:35 EDTVEEVVeeva price target raised to $35 from $32 at JPMorgan
Subscribe for More Information
November 25, 2014
18:18 EDTVEEVOn The Fly: After Hours Movers
Subscribe for More Information
16:08 EDTVEEVVeeva sees FY14 non-GAAP EPS 33c-34c, consensus 31c
Subscribe for More Information
16:07 EDTVEEVVeeva sees Q4 non-GAAP EPS 8c-9c, consensus 7c
Sees Q4 revenue $84.5M-$85.5M, consensus $81.62M.
16:06 EDTVEEVVeeva reports Q3 non-GAAP EPS 7c, consensus 8c
Subscribe for More Information
15:31 EDTVEEVNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Hewlett-Packard (HPQ), consensus $1.06; Analog Devices (ADI), consensus 68c; Cubic (CUB), consensus 94c; Nimble Storage (NMBL), consensus (16c); Veeva Systems (VEEV), consensus 8c; Infoblox (BLOX), consensus 3c; TiVo (TIVO), consensus 7c; Perfect World (PWRD), consensus 40c.
14:29 EDTVEEVVeeva technical comments ahead of results
The shares for the last several months have been trading largely within the range of $25 at the low and $30 at the high. Those two bounds and how price behaves around them may give us important information about post-earnings price reactions. Currently the stock is trading close to the upper end of the range. If the news is positive, a run to $30 would appear to be highly probable. A breakout above $30 would resolve the current trading range bullishly. Next resistance levels as potential upside objectives would be at $31.56 and then at $33.47. If the news is a disappointment, it is probable that the low of the range would be tested. On the way to such a test an intermediate support level would be at $27.44. A test of $25 that does not break it would leave the shares range bound. On an extreme move, support below $25 would be at $23.68.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use